Regulatory effect of IL-38 on NF-κB pathway in systemic lupus erythematosus-Reference-Cited by-同舟云学术

Regulatory effect of IL-38 on NF-κB pathway in systemic lupus erythematosus

Published:2023-03 Issue:2 Volume:228 Page:152322
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Zhang Jiyun,Tabush Nurshati,Wei Chune,Luo Li

Funder

Xinjiang Medical University

Natural Science Foundation of Xinjiang

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference39 articles.

1. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17;Aggarwal;J. Biol. Chem.,2003

2. Research progress on the level of Toll-like receptor nuclear factor-κB in patients with systemic lupus erythematosus;Bai;Practical J. Clin. Med.,2010

3. Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14;Bensen;J. Interferon Cytokine Res.,2001

4. Recent advances in understanding NF-kappaB regulation;Boone;Inflamm. Bowel Dis.,2002

5. IL-36, IL-37, and IL-38 cytokines in skin and joint inflammation: a comprehensive review of their therapeutic potential;Boutet;Int. J. Mol. Sci.,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low heterozygosity for rs3811050, a 5 prime untranslated region variant of the gene encoding interleukin-38 (IL1F10), is associated with a reduced risk of systemic lupus erythematosus;Egyptian Journal of Medical Human Genetics;2024-03-21

2. The emerging role of IL‐38 in diseases: A comprehensive review;Immunity, Inflammation and Disease;2023-08